Navigation Links
Cellceutix Discovers Drug Activates 'Guardian Angel p53' in Fight Against Leukemia
Date:3/7/2011

BEVERLY, Mass., March 7, 2011 /PRNewswire/ -- Cellceutix Corporation (OTCQB: CTIX) today reported that its flagship cancer compound, Kevetrin™, has demonstrated potent anti-tumor activity in the treatment of leukemia cells in a hematopoietic xenograft tumor model.  The activity, once again, is attributed to the reactivation of p53, the "Guardian Angel" protein, which Cellceutix announced last week as a major breakthrough in cancer research.  

The data was presented to Cellceutix Scientific Advisor, Emil Frei III, MD, who is Physician-in-Chief emeritus at Harvard University's world renowned Dana-Farber Cancer Institute and Distinguished Professor of Medicine at Harvard Medical School.  Dr. Frei was honored by the American Association for Cancer Research with its inaugural lifetime achievement award for revolutionizing chemotherapy and his role in developing the first treatment leading to the complete cure for childhood leukemia. ( http://www.dana-farber.org/abo/news/press/040704.asp ) After reviewing the most recent data on Kevetrin's method of action regarding leukemia, Dr. Frei commented, "The p53 mechanism of Kevetrin as a possible new therapy for leukemia is very exciting and holds significant promise. After Dr. Menon's years of hard work, I am impressed with the progress of this novel compound. I look forward to the commencement of human trials and the realization of Kevetrin's potential as a new therapy for a wide array of cancers."

Data from the NCI-60 DTP Human Tumor Cell Line Screen showed that Kevetrin was effective in killing leukemia cells in vitro. Accordingly, the activity of Kevetrin was evaluated in nude mice bearing established human chronic myelogenous leukemia tumors, K-562. After administration of 200 mg/kg every other day per week for 3 weeks, Kevetrin significantly reduced the average tumor volume by 84% (day 24, p< 0.01). Tumors in mice t
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Video: New Research Discovers Independent Brain Networks Control Human Walking
4. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
5. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
6. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
7. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
8. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
9. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
10. deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
11. deCODE Discovers Four New Risk Factors for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 The International Myeloma Foundation (IMF) – ... working toward prevention and a cure – today commended ... federal resolution (H. Res. 174) that supports the designation ... Myeloma Awareness Month." Currently there are more ... than 110,000 new cases are diagnosed yearly, according to ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... Huntington Memorial Hospital is the first facility ... valve replacement (TAVR), a minimally invasive replacement of heart ... to replace an aortic valve without a chest incision ... The procedure is performed by a dedicated Huntington ... Durairaj , MD, interventional cardiologist and Robbin Cohen ...
Breaking Medicine Technology:The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... hip injuries is a growing field in orthopaedic medicine. ... with labral tear to confirm the pain etiology, research ... Medicine’s ( AOSSM ) Specialty Day suggests that pain ... outcomes following arthroscopic hip surgery. , “Our study ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... for patients with Type V AC joint injuries, according ... study, presented today at the American Orthopaedic Society for ... personnel returned to duty faster when surgery was not ... patients, with 7 receiving surgical treatment and 17 receiving ...
(Date:3/28/2015)... 2015 Andrew Hawley of Vintage Rock Posters ... concert posters. The Who and the Doors played together at ... 1968. According to Hawley, “The Who toured the United States ... college campuses. Perhaps the most famous Who poster was a ... the Doors on August 2, 1968 at the Singer Bowl ...
(Date:3/28/2015)... 28, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Physical Therapy Association Annual Conference to be held ... Hotel in Columbus, OH. , The OPTA ... exhibits with products and services. , Representatives ...
(Date:3/28/2015)... The "Petrick Sustainable Health System" ... After 18 years of research and experience with patients ... Dr. Jon Petrick is excited to be launching his ... the immediate benefits of this radical new system are ... strength of the immune system, faster healing of injuries, ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For&nbsp;Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2
... -- Mayo Clinic has clarified the methods of diagnosis ... vessel disease of the brain and spinal cord that ... system vasculitis (PCNSV) can best be identified through a ... cerebral arteries), brain biopsy and other laboratory studies. , ...
... Inc. (Nasdaq: PMTI ), a leading developer of ... cosmetic treatments, will hold its,quarterly conference call of its ... at 11:30AM Eastern Time. If you would like to,participate, ... on that,day. The telephone replay will be available one ...
... the World,s First Accurate Non-Contact Clinical Thermometer, ... a division of,American Scientific Resources, (ASFX-OTC) today announced ... first non-contact clinical,thermometer in the world, now available ... 5-in-1, made in Italy and long,recommended by doctors ...
... no proof they help children under 6, and they may ... -- Beginning Thursday, a panel of experts at the U.S. ... over-the-counter cough and cold medicines for young children. , Such ... the FDA, who published a 365-page review on the issue ...
... a leading provider,of business intelligence solutions that combine ... announced this week that its,longstanding client, Miller Children,s ... children,s hospitals named to the 2007 Leapfrog Top ... its outstanding,performance," said Swati Abbott, President of MEDai. ...
... the evidence shows no link , THURSDAY, Oct. 18 (HealthDay ... stretching before or after exercise will not prevent muscle soreness, ... 10 studies, each involving from 10 to 30 people. , ... laboratory settings, and the time spent stretching by participants varied ...
Cached Medicine News:Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 2Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 3Health News:Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast 2Health News:Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide 2Health News:Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide 3Health News:FDA Panel Weighs Ban on Kids' Cold Medicines 2Health News:FDA Panel Weighs Ban on Kids' Cold Medicines 3Health News:FDA Panel Weighs Ban on Kids' Cold Medicines 4Health News:Leading Children's Hospital Utilizes MEDai's Solutions to Deliver Outstanding Care 2
... allows detection of SYBR Green I or ... range of fluorophores in the second channel ... for a multitude of applications such ... thermal cycler offers precision thermal control and ...
Inquire...
... SmartCycler System is a rapid, real-time thermal ... biological samples. By automating much of the ... individually programmable, it is the fastest, easiest ... on the market. The SmartCycler delivers highly ...
Chemically Resistant Sealing Mat for 96ch, 1.1ml or 2.0ml, Deep Well, Round Available Sterile...
Medicine Products: